99 related articles for article (PubMed ID: 21807037)
1. Curcumin derivatives as new ligands of Aβ peptides.
Airoldi C; Zona C; Sironi E; Colombo L; Messa M; Aurilia D; Gregori M; Masserini M; Salmona M; Nicotra F; La Ferla B
J Biotechnol; 2011 Dec; 156(4):317-24. PubMed ID: 21807037
[TBL] [Abstract][Full Text] [Related]
2. Curcumin Binding to Beta Amyloid: A Computational Study.
Rao PP; Mohamed T; Teckwani K; Tin G
Chem Biol Drug Des; 2015 Oct; 86(4):813-20. PubMed ID: 25776887
[TBL] [Abstract][Full Text] [Related]
3. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
Yang F; Lim GP; Begum AN; Ubeda OJ; Simmons MR; Ambegaokar SS; Chen PP; Kayed R; Glabe CG; Frautschy SA; Cole GM
J Biol Chem; 2005 Feb; 280(7):5892-901. PubMed ID: 15590663
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 1-(4-[¹⁸F]fluoroethyl)-7-(4'-methyl)curcumin with improved brain permeability for β-amyloid plaque imaging.
Lee I; Yang J; Lee JH; Choe YS
Bioorg Med Chem Lett; 2011 Oct; 21(19):5765-9. PubMed ID: 21885280
[TBL] [Abstract][Full Text] [Related]
5. Computational Study of the Driving Forces and Dynamics of Curcumin Binding to Amyloid-β Protofibrils.
Martin TD; Malagodi AJ; Chi EY; Evans DG
J Phys Chem B; 2019 Jan; 123(3):551-560. PubMed ID: 30571122
[TBL] [Abstract][Full Text] [Related]
6. Computational Evaluation of Interaction Between Curcumin Derivatives and Amyloid-β Monomers and Fibrils: Relevance to Alzheimer's Disease.
Orjuela A; Lakey-Beitia J; Mojica-Flores R; Hegde ML; Lans I; Alí-Torres J; Rao KS
J Alzheimers Dis; 2021; 82(s1):S321-S333. PubMed ID: 33337368
[TBL] [Abstract][Full Text] [Related]
7. Curcumin derivative with the substitution at C-4 position, but not curcumin, is effective against amyloid pathology in APP/PS1 mice.
Yanagisawa D; Ibrahim NF; Taguchi H; Morikawa S; Hirao K; Shirai N; Sogabe T; Tooyama I
Neurobiol Aging; 2015 Jan; 36(1):201-10. PubMed ID: 25179227
[TBL] [Abstract][Full Text] [Related]
8. Curcuminoid binds to amyloid-β1-42 oligomer and fibril.
Yanagisawa D; Taguchi H; Yamamoto A; Shirai N; Hirao K; Tooyama I
J Alzheimers Dis; 2011; 24 Suppl 2():33-42. PubMed ID: 21335654
[TBL] [Abstract][Full Text] [Related]
9. Insights into the Interaction Mechanism of Ligands with Aβ42 Based on Molecular Dynamics Simulations and Mechanics: Implications of Role of Common Binding Site in Drug Design for Alzheimer's Disease.
Kundaikar HS; Degani MS
Chem Biol Drug Des; 2015 Oct; 86(4):805-12. PubMed ID: 25763767
[TBL] [Abstract][Full Text] [Related]
10. Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide.
Taylor M; Moore S; Mourtas S; Niarakis A; Re F; Zona C; La Ferla B; Nicotra F; Masserini M; Antimisiaris SG; Gregori M; Allsop D
Nanomedicine; 2011 Oct; 7(5):541-50. PubMed ID: 21722618
[TBL] [Abstract][Full Text] [Related]
11. Solid-state NMR analysis of interaction sites of curcumin and 42-residue amyloid β-protein fibrils.
Masuda Y; Fukuchi M; Yatagawa T; Tada M; Takeda K; Irie K; Akagi K; Monobe Y; Imazawa T; Takegoshi K
Bioorg Med Chem; 2011 Oct; 19(20):5967-74. PubMed ID: 21924918
[TBL] [Abstract][Full Text] [Related]
12. Low-n oligomers as therapeutic targets of Alzheimer's disease.
Ono K; Yamada M
J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429
[TBL] [Abstract][Full Text] [Related]
13. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
[TBL] [Abstract][Full Text] [Related]
14. Curcumin alters the salt bridge-containing turn region in amyloid β(1-42) aggregates.
Mithu VS; Sarkar B; Bhowmik D; Das AK; Chandrakesan M; Maiti S; Madhu PK
J Biol Chem; 2014 Apr; 289(16):11122-11131. PubMed ID: 24599958
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory Activity Of Curcumin Derivatives Towards Metal-free And Metal-induced Amyloid-β Aggregation.
Kochi A; Lee HJ; Vithanarachchi SM; Padmini V; Allen MJ; Lim MH
Curr Alzheimer Res; 2015; 12(5):415-23. PubMed ID: 25938870
[TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics simulations of Aβ fibril interactions with β-sheet breaker peptides.
Bruce NJ; Chen D; Dastidar SG; Marks GE; Schein CH; Bryce RA
Peptides; 2010 Nov; 31(11):2100-8. PubMed ID: 20691234
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of curcumin on the Al(III)-induced Aβ₄₂ aggregation and neurotoxicity in vitro.
Jiang T; Zhi XL; Zhang YH; Pan LF; Zhou P
Biochim Biophys Acta; 2012 Aug; 1822(8):1207-15. PubMed ID: 22561904
[TBL] [Abstract][Full Text] [Related]
18. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
Xu L; Chen Y; Wang X
Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
[TBL] [Abstract][Full Text] [Related]
19. The effect of curcumin on the stability of Aβ dimers.
Zhao LN; Chiu SW; Benoit J; Chew LY; Mu Y
J Phys Chem B; 2012 Jun; 116(25):7428-35. PubMed ID: 22690789
[TBL] [Abstract][Full Text] [Related]
20. Curcumin-conjugated nanoliposomes with high affinity for Aβ deposits: possible applications to Alzheimer disease.
Lazar AN; Mourtas S; Youssef I; Parizot C; Dauphin A; Delatour B; Antimisiaris SG; Duyckaerts C
Nanomedicine; 2013 Jul; 9(5):712-21. PubMed ID: 23220328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
